Larson Financial Group LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1731061
ST LOUIS, MO
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$390,959
-$42,492 QoQ
Shares Held
627
+11.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#871
of 1,322 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $5,564,070 across 194 Biotechnology names. REGN ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,302 | $646,742 | |
| 2 | INCY |
Incyte Corp
|
4,050 | $459,108 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
7,292 | $400,622 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
627 | $390,959 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,507 | $245,225 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,000 | $237,870 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
613 | $184,531 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
709 | $170,847 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $390,959 | 627 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $433,451 | 561 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $376,672 | 488 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $251,896 | 448 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $92,925 | 177 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $33,614 | 53 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $57,698 | 81 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $52,562 | 50 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $23,122 | 22 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $48,124 | 50 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $55,332 | 63 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $59,253 | 72 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $9,341 | 13 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $10,681 | 13 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $9,379 | 13 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $8,955 | 13 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $7,684 | 13 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $67,048 | 96 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $46,732 | 74 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $67,780 | 112 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $62,556 | 112 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $44,475 | 94 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $45,412 | 94 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $34,146 | 61 | Shares | Sole | 2020-10-08 | |
| No filing history on record for this holder in this stock. | ||||||